Veraxa Biotech AG Ordinary Shares
Price & Volume
Stats
See more52W Range | $1.04-$27.36 |
Market Cap | $155.5M |
Shares Short | 235,019 |
Financials
See moreRevenue (12 Mos) | $23,426 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $15,461 |
Diluted EPS | -$0.57 |
News
See moreYahoo Finance • 25 days ago
VERAXA Biotech (VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase
About
CEO | Dr. Christoph Antz Ph.D. |
Address | Im Neuenheimer Feld 584, Heidelberg, Germany, 69120 |
Sector | Healthcare |
Industry | Biotechnology |